Research
Filters
What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?
June 02, 2025Chronic inflammatory enteropathies in dogs are characterized by persistent or recurrent gastrointestinal signs that last for more than 3 weeks....
Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies
June 02, 2025Background: Calprotectin is a marker of inflammation, but its clinical utility in dogs with chronic inflammatory enteropathies (CIE) is unknown....
Canine Inflammatory Bowel Disease: Current and Prospective Biomarkers for Diagnosis and Management. Compendium
January 28, 2025Inflammatory bowel disease (IBD) is a common gastrointestinal disorder in dogs. Current management strategies for this disease typically involve assessing...
NEW DIAGNOSTIC TEST FOR DOGS WITH CHRONIC GASTROINTESTINAL SIGNS
March 15, 2024A gliadin-free diet should be considered in cases of elevated Antigliadin IgA. Research has noted that dogs with gastrointestinal disease had...
CANINE CHRONIC ENTEROPATHY—CURRENT STATE-OF-THE-ART AND EMERGING CONCEPTS
March 15, 2024Over the last decade, chronic inflammatory enteropathies (CIE) in dogs have received great attention in the basic and clinical...
SEROLOGIC AND FECAL MARKERS TO PREDICT RESPONSE TO INDUCTION THERAPY IN DOGS WITH IDIOPATHIC INFLAMMATORY BOWEL DISEASE
February 27, 2024“Our data indicate that measurement of fecal cCP (calprotectin) concentration is a useful biomarker for noninvasive evaluation of intestinal inflammation.” ...
FECAL CALPROTECTIN CONCENTRATIONS IN CATS WITH CHRONIC ENTEROPATHIES
February 27, 2024These findings suggest that fecal calprotectin may have utility as a clinical biomarker for feline chronic enteropathies. It further...